Framingham, MA, United States of America

Thomas P Jerussi

This inventor holds 53 USPTO granted patents and 3 published patent applications, plus 4 CIPO patents and 2 EPO patents, primarily in CNS Disorders Treatment (CPC class A61K). Top assignees: Sepracor, Inc., Sunovion Pharmaceuticals Inc., Swpracor, Inc.. Active years: 1998-2020.

USPTO Granted Patents = 53 (Patent Applications = 3)

% Patents Active = 73.6

CIPO Patents = 4 (Patent Applications = 8)

EPO Patents = 2

Average Co-Inventor Count = 2.5

ph-index = 11

Forward Citations = 471(Granted Patents)

Forward Citations (Not Self Cited) = 398(Dec 10, 2025)

Inventors with similar research interests:

Location History:

Framingham, MA (US) (1998 - 2015)
Charleston, SC (US) (2006 - 2020)

Company Filing History:

Sunovion Pharmaceuticals Inc.

5. 1 out of 834,453

Other

patents

Years Active: 1998-2020

Loading Chart...

Areas of Expertise:

CNS Disorders

Venlafaxine Derivatives

Anxiolytics

Zopiclone Derivatives

Erectile Dysfunction

Neuropathic Pain

Antipsychotic Therapy

Muscle Spasms

Affective Disorders

Weight Gain

Tinnitus Treatment

53 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10702486 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2020-07-07),

2. 10328036 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2019-06-25),

3. 9907764 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2018-03-06),

4. 9498452 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-naphthalenamine (2016-11-22),

5. 9072700 - Methods of using derivatives of (−)-venlafaxine (2015-07-07),

6. 9072699 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine (2015-07-07),

7. 8658700 - [object Object] (2014-02-25),

8. 8642662 - Methods of using derivatives of (−)-venlafaxine (2014-02-04),

9. 8344030 - [object Object] (2013-01-01),

10. 8269040 - Derivatives of venlafaxine and methods of preparing and using the same (2012-09-18),

11. 8134029 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine (2012-03-13),

12. 7790772 - [object Object] (2010-09-07),

13. 7723324 - Imidazo[1,2-A]pyridine anxiolytics (2010-05-25),

14. 7589237 - Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine (2009-09-15),

15. 7566725 - Imidazo[1,2-A] pyridine anxiolytics (2009-07-28),

Title: The Inventive Journey of Thomas P Jerussi

Introduction: Thomas P Jerussi is a prolific inventor hailing from Framingham, MA, whose innovative spirit has led to groundbreaking creations in various fields.

Latest Patents: Thomas P Jerussi holds several patents in the areas of technology, healthcare, and consumer products, with his most recent inventions focusing on sustainable energy solutions and smart home devices.

Career Highlights: Throughout his career, Thomas P Jerussi has worked with leading research institutions and companies to bring his inventions to life. His dedication to pushing the boundaries of technology has earned him recognition as a visionary in the innovation world.

Collaborations: Thomas P Jerussi has collaborated with top engineers, scientists, and designers to develop cutting-edge products that have revolutionized their respective industries. His ability to work seamlessly in multidisciplinary teams has been key to his success as an inventor.

Conclusion: In conclusion, Thomas P Jerussi's passion for innovation and his relentless drive to create have cemented his legacy as a pioneering inventor. His contributions to the world of technology continue to inspire future generations of inventors.